# TOFACITINIB CITRATE

NDC: 0574-1811
Generic name: Tofacitinib Citrate
Labeler / Manufacturer: Padagis US LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20260615

FDA application: ANDA216001

## Active ingredients

- TOFACITINIB CITRATE: 11 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0574-1811"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0574-1811
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=df24e90d-4b2c-4f9d-a1d6-fcb1ab00606f